Alex is passionate about the Life Sciences sector and advises about regulatory issues all day every day. Alex’s advice is informed by a BSc in Human Genetics and in-house experience including as GC of a biopharmaceutical company and brings 25 years’ experience advising clients in the sector.
In addition to a wide array of contentious (judicial review) matters, he enjoys working with clients to devise and implement regulatory strategies throughout the product life cycle of pharmaceuticals and medical devices.
Alex has advised a number of clients in relation to challenging issues including genomics, cell and gene therapies, 3D printing, healthcare Apps, companion diagnostics, borderline products and combination products.
Alex has been involved in the development of a number of regulatory frameworks and guidelines.
Legal 500 describes Alex as “a straight-talking, commercially astute technology specialist who is always willing to take a view” and who delivers “out-of-the-box solutions”.
- LLB, University of New South Wales
- BSc Human Genetics, University of New South Wales
- Qualified 1995
- Partner 2018
What others say
"Alex Denoon often handles the complex regulatory aspects of acquisitions and commercial transactions."Chambers and Partners 2021
"Alex is a good example of how external counsel can add true value to a business."Legal 500 2021
"He [Alex Denoon] took the time to understand how our business works and retained that information for future consultations."Legal 500 2021
"Alex Denoon: Sharp, practical and showing a clear understanding of the issues that our business was focused on and cared about. "Legal 500 2021
"Alex Denoon won the trust of our team from the outset. "Legal 500 2021
"Alex Denoon is 'sharp, practical and shows a clear understanding of the issues'."Legal 500 2021
"Alex Denoon is an excellent regulatory expert. It’s a great experience working with him."Legal 500 2020
Life Sciences: Regulatory
Chambers and Partners 2021
Life Sciences and Healthcare (leading individual)
Legal 500 2021
Life Sciences: Regulatory and Transactional
Who's Who Legal (2020)